📌 Key Takeaways
- Topic: Tosoh Silica: Product Range, Applications and Key Grades
- Keywords: silicon dioxide
- Published: 2026-11-20 10:38:53
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Bulk Density: Typical Values by Type and Why It Matters for Handling
- Silica as a Thickening Agent: How It Works in Liquids, Resins and Gels
- What Is Fused Quartz? Properties, Manufacturing Process and Applications
- Mesoporous silica nanoparticles (MSNs) are recognized as a prime example of nanotechnology applied in the biomedical field, owing to their readily tunable structure and composition, various surface functionalization properties, and excellent biocompatibility. Over the past two decades, researchers have developed a wide range of MSNs-based nanoplatforms through careful design and controlled preparation approaches, demonstrating their adaptability to diverse biomedical application scenarios. With the continuous breakthroughs of MSNs in the fields of biosensing, disease diagnosis and treatment, tissue engineering, etc., MSNs are steadily moving from basic research to clinical trials. In this review, we supply a detailed summary of MSNs in the biomedical field, beginning with a comprehensive overview of their expansion history. We then discuss the types of MSNs-based nanostructured architectures, along with the classification of MSNs-based nanocomposites according to the elements existed in diverse inorganic functional factors. Subsequently, we summarize the primary purposes of surface-functionalized modifications of MSNs. In the following, we examine the biomedical applications of MSNs, and highlight the MSNs-based targeted therapeutic modalities currently developed. Given the importance of clinical translation, we also summarize the progress of MSNs in clinical trials. Lastly, we take a perspective on the future direction and remaining difficulties of MSNs in the biomedical field.
- Sibelco Quartz: Product Range, Purity Grades and Applications
- Silica as a Reinforcing Agent: How It Improves Strength in Rubber and Polymers
What Is the Refractive Index of Silica? Values for Fused Silica, Quartz and Amorphous Silica
What is silica (SiO₂)?
spherical silica Liu, S. et al. Upconversion nanoparticles regulated drug & gas dual-effective nanoplatform for the targeting cooperated therapy of thrombus and anticoagulation. Bioact. Mater. 18, 91-103 (2022). PubMed Central PubMed Google Scholar
What is the difference between fumed silica and precipitated silica?
Grace Syloid
What drives silica raw material prices?
Cabot Cab-O-Sil Along with targeted ligand, cell membrane-based biomimetic strategy is also a current and really feasible approach to enhance the targeting skill of MSNs (Fig. 6b ). The cell membrane biomimetic method dates back to 2011, when Zhang's group used intact red blood cell membranes to encapsulate NPs via a top-down strategy. Compared with unencapsulated NPs, NPs encapsulated by red blood cell membranes have a longer half-life in mice and remain in circulation for up to 72 h due to the immune escape function possessed by the cell membrane. 326 The preparation process is typically divided into three steps: membrane extraction, preparation of inner core NPs, and fusion of membrane and NPs. The cell membrane-coated NPs combine the benefits of outer cells and inner core NPs, and achieve long-term in vivo circulation and targeted delivery while greatly improving biocompatibility. 327 The therapeutic potential of diverse types of cell membranes-engineered MSNs-based drug delivery systems has been demonstrated in a variety of disease models. For example, platelet membrane-coated MSNs were used for early atherosclerosis therapy by mimicking the immune escape ability of platelet. 328 Cancer cell membrane-coated MSNs were specifically enriched in tumor sites by homologous targeting properties, and activated the ferroptosis-related immunogenic cell death on gastric cancer. 329 Bacterial outer membrane-coated MSNs are used for targeted delivery of the antibiotic rifampicin to achieve in vivo resistance to gram-negative bacterial infections. 330 Despite the limitations of current research related to cell membrane biomimetic tactic, these instances invariably show the effectiveness of cell membrane-based active targeting strategy in enhancing the targeting ability and therapeutic efficacy of MSNs.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.